Healthy adults to test new drug NBX-100 in first human study
Knowledge-focused
Not yet recruiting
This early-stage study tests the safety and how the body handles a new drug called NBX-100 in 8 healthy adults aged 21-50. Participants receive four weekly doses and have frequent check-ups, including blood tests and psychological assessments. The goal is to gather safety and dru…
Phase: PHASE1 • Sponsor: Neurala Biosciences • Aim: Knowledge-focused
Last updated May 17, 2026 09:08 UTC